1. Kasuga, Yusuke, Ouda, Ryota, Watanabe, Masashi, Hatakeyama, Shigetsugu, Kobayashi, Koichi S. 2023. FBXO11 constitutes a major negative regulator of MHC class II through ubiquitin-dependent proteasomal degradation of CIITA. In Proceedings of the National Academy of Sciences of the United States of America, 120, e2218955120. doi:10.1073/pnas.2218955120. https://pubmed.ncbi.nlm.nih.gov/37279268/
2. Dubois, Patrick C A, Trynka, Gosia, Franke, Lude, Wijmenga, Cisca, van Heel, David A. 2010. Multiple common variants for celiac disease influencing immune gene expression. In Nature genetics, 42, 295-302. doi:10.1038/ng.543. https://pubmed.ncbi.nlm.nih.gov/20190752/
3. Su, Chenhe, Lu, Fang, Soldan, Samantha S, Kossenkov, Andrew V, Lieberman, Paul M. 2021. EBNA2 driven enhancer switching at the CIITA-DEXI locus suppresses HLA class II gene expression during EBV infection of B-lymphocytes. In PLoS pathogens, 17, e1009834. doi:10.1371/journal.ppat.1009834. https://pubmed.ncbi.nlm.nih.gov/34352044/
4. Eike, M C, Skinningsrud, B, Ronninger, M, Undlien, D E, Lie, B A. 2012. CIITA gene variants are associated with rheumatoid arthritis in Scandinavian populations. In Genes and immunity, 13, 431-6. doi:10.1038/gene.2012.11. https://pubmed.ncbi.nlm.nih.gov/22513452/
5. Gyllenberg, A, Piehl, F, Alfredsson, L, Olsson, T, Kockum, I. 2014. Variability in the CIITA gene interacts with HLA in multiple sclerosis. In Genes and immunity, 15, 162-7. doi:10.1038/gene.2013.71. https://pubmed.ncbi.nlm.nih.gov/24430172/
6. León Machado, Jorge Alfonso, Steimle, Viktor. 2021. The MHC Class II Transactivator CIITA: Not (Quite) the Odd-One-Out Anymore among NLR Proteins. In International journal of molecular sciences, 22, . doi:10.3390/ijms22031074. https://pubmed.ncbi.nlm.nih.gov/33499042/
智鼠故事 
